Ensayos clínicos

Inclusion Criteria:

• Participants must be female.
• Participants must have a pre-operative standard mammogram with or without ultrasound.
• Participants must have biopsy confirmed and clinical stage I, stage II, or stage III non-inflammatory breast carcinoma (If biopsy was done at an outside hospital, pathology will be reviewed at MCR).
• Patient must meet standard MRI guidelines and be able and willing to undergo MRI.
• Participants will be restricted to those aged ≥18 and <80 years old.
• Participants must understand the study and be willing to sign a written informed consent document.

Exclusion Criteria:

• Participants with inflammatory breast cancer.
• Participants who are pregnant and/or lactating.
• Participants who are already enrolled in a conflicting investigational trial.
• Participants with known active collagen vascular disease.
• Participants with known implantable devices or breast implants.
• Participants with prior history of ipsilateral breast carcinoma treated with BCS and radiation therapy.
• Participants who are unable to undergo MRI because of documented contra-indications for contrast-enhanced MRI (including but not limited to renal failure).
• Participants who exceed the weight limit for the operative surgical table, 350 lbs or who will not fit into the 60 cm diameter bore of the MRI scanner.